| 1 |
35115509 | The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression. | 2022 Feb 3 |
7 |
| 2 |
32579788 | Targeting Wnt/β-catenin by anthelmintic drug niclosamide overcomes paclitaxel resistance in esophageal cancer. | 2021 Feb |
5 |
| 3 |
31433913 | Injectable pegylated niclosamide (polyethylene glycol-modified niclosamide) for cancer therapy. | 2020 Jan |
1 |
| 4 |
27492973 | Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia. | 2017 Feb 1 |
3 |
| 5 |
28861168 | Inhibition of Wnt/β-catenin by anthelmintic drug niclosamide effectively targets growth, survival, and angiogenesis of retinoblastoma. | 2017 |
1 |
| 6 |
26873959 | Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma. | 2016 Jul 15 |
1 |
| 7 |
27652012 | Niclosamide suppresses renal cell carcinoma by inhibiting Wnt/β-catenin and inducing mitochondrial dysfunctions. | 2016 |
5 |